Pestana Roberto Carmagnani, Lopes David Bruna Bianca, Pires de Camargo Veridiana, Munhoz Rodrigo Ramella, Lopes de Mello Celso Abdon, González Donna María Lucila, Haro Varas Juan Carlos, Zapata Maycos L, Cunha Martins Cicero Luiz, Chacon Matias, Schmerling Rafael, Jesus-Garcia Reynaldo
Latin American Cooperative Oncology Group, Porto Alegre, Brazil.
Hospital Israelita Albert Einstein, São Paulo, Brazil.
Lancet Reg Health Am. 2024 Jan 4;30:100671. doi: 10.1016/j.lana.2023.100671. eCollection 2024 Feb.
As a developing region, Latin America faces unique cancer control and prevention challenges, which are intensified when considering rare cancers, including sarcomas. Sarcomas are a group of malignancies that arise in the connective tissues of the body-such as muscle, fat, nerves, blood vessels, and bones-accounting for a diverse range of tumours that, although rare, require specialized attention. Sarcoma care and research in Latin America require a comprehensive approach that includes deeper epidemiologic knowledge, diagnostic capacity building, access to innovative treatments, increased patient advocacy, and strengthening of clinical research capacity. This article will review current challenges and opportunities for treating patients with sarcoma in Latin America and outline a pathway toward improvement for regional collaborative groups.
作为一个发展中地区，拉丁美洲面临着独特的癌症控制和预防挑战，在考虑包括肉瘤在内的罕见癌症时，这些挑战会更加严峻。肉瘤是一组起源于身体结缔组织（如肌肉、脂肪、神经、血管和骨骼）的恶性肿瘤，涵盖了各种各样的肿瘤，尽管罕见，但需要特别关注。拉丁美洲的肉瘤护理和研究需要一种全面的方法，包括更深入的流行病学知识、诊断能力建设、获得创新治疗、加强患者宣传以及增强临床研究能力。本文将回顾拉丁美洲治疗肉瘤患者目前面临的挑战和机遇，并概述区域协作组的改进途径。
